Sign in

Private company

Bionik Laboratories Corp.

American orthopedic company, incorporated in Delaware1

In its 2023 annual report the company says: “Bionik Laboratories Corp. is a robotics company providing neurological functional recovery solutions to improve the quality of life of millions of people with functional or mobility impairments by combining artificial intelligence, innovative technology and data solutions to help individuals regain mobility, enhance autonomy, and regain self-esteem.”57 It is headquartered in Watertown, Massachusetts.1

Last updated Oct 21, 2026.

Overview

$1.8MRevenue, fiscal 20232
-$4.9MNet income, fiscal 20232
  • IndustryOrthopedic, Prosthetic & Surgical Appliances & Supplies1
  • HeadquartersWatertown, Massachusetts1
  • Incorporated inDE3
  • Business address80 Coolidge Hill Road, Watertown, Ma 024723
  • Filer categoryNon-accelerated filer, Smaller reporting company3

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2023

54.8%Gross margin2
-267.3%Operating margin2
-274.0%Net margin2
41.7%Revenue growth, 20232

Where the money goes

Where each dollar of revenue went, fiscal 2023

  • Cost of revenue45¢$815.3K
  • Research and development49¢$903.2K
  • Interest6¢$107.2K

Out of $1.8M in revenue.2 The company lost money this year.

Financial statements

Revenue45672$1.8M in 2023
0$1.0M$2.0M$3.0M2016: $0$020162017: $571.9K$571.9K20172018: $987.4K$987.4K2018+73%2020: $2.2M$2.2M2020+118%2021: $1.2M$1.2M2021−45%2022: $1.3M$1.3M2022+7%2023: $1.8M$1.8M2023+42%
Gross profit4589672$989.9K in 2023
0$500.0K$1.0M$1.5M$2.0M2016: $0$020162017: $183.2K$183.2K20172018: $584.8K$584.8K2018+219%2019: $1.6M$1.6M2019+176%2020: $1.3M$1.3M2020−22%2021: $923.8K$923.8K2021−27%2022: $953.3K$953.3K2022+3%2023: $989.9K$989.9K2023+4%
Operating income672-$4.8M in 2023−81% since 2020
-$30.0M-$20.0M-$10.0M02020: -$25.1M-$25.1M20202021: -$13.3M-$13.3M2021−47%2022: -$10.0M-$10.0M2022−25%2023: -$4.8M-$4.8M2023−52%
Net income4589672-$4.9M in 2023
-$30.0M-$20.0M-$10.0M0$10.0M$20.0M2016: $1.0M$1.0M20162017: -$8.1M-$8.1M20172018: $14.6M$14.6M20182019: -$10.6M-$10.6M20192020: -$25.0M-$25.0M2020+137%2021: -$13.6M-$13.6M2021−46%2022: -$10.4M-$10.4M2022−24%2023: -$4.9M-$4.9M2023−52%
Fiscal year20162017201820192020202120222023
Revenue$04$571.9K5$987.4K5$2.2M6$1.2M7$1.3M2$1.8M2
Cost of revenue$04$388.8K5$402.7K8$1.6M9$893.4K6$269.6K7$320.5K2$815.3K2
Gross profit$04$183.2K5$584.8K8$1.6M9$1.3M6$923.8K7$953.3K2$989.9K2
Research and development$1.4M4$2.7M5$2.8M8$3.2M9$3.9M6$1.5M7$998.5K2$903.2K2
Operating expenses$10.9M2$5.8M2
Operating income-$25.1M6-$13.3M7-$10.0M2-$4.8M2
Interest$2.8K4$43.7K5$1.3M5$181.9K6$405.3K7$825.2K2$107.2K2
Income before tax-$10.4M2-$4.9M2
Income tax$04$05$08$09$06$07$02$02
Net income$1.0M4-$8.1M5$14.6M8-$10.6M9-$25.0M6-$13.6M7-$10.4M2-$4.9M2
Earnings per share$0.014-$0.095-$2.667-$1.782-$0.722
Earnings per share (diluted)-$0.084-$0.095-$2.667-$1.782-$0.722
Shares (weighted, basic)5.8M shares26.9M shares2
Shares (weighted, diluted)5.8M shares26.9M shares2

Compare Bionik Laboratories Corp. with another company

What it owns

What Bionik Laboratories Corp. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, before depreciation$847.0K2 Mar 31, 2023$689.9K2 Mar 31, 2022+22.8%
Accumulated depreciation$659.3K2 Mar 31, 2023$598.7K2 Mar 31, 2022+10.1%
Property and equipment, net$187.7K2 Mar 31, 2023$91.2K2 Mar 31, 2022+105.7%
Operating-lease assets (leased space)$254.7K2 Mar 31, 2023$02 Mar 31, 2022

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$427.4K2 Mar 31, 2023$2.0M2 Mar 31, 2022−78.5%

Intangibles and goodwill

ItemLatestA year beforeChange
Goodwill$99.6K2 Mar 31, 2023$02 Mar 31, 2022
Intangible assets, net (excluding goodwill)$34.0K2 Mar 31, 2023$07 Mar 31, 2022
Accumulated amortization$100.0K2 Mar 31, 2023$100.0K2 Mar 31, 20220%
Finite-lived intangibles, net$34.0K2 Mar 31, 2023$02 Mar 31, 2022

Inventory

ItemLatestA year beforeChange
Inventory, total$1.0M2 Mar 31, 2023$1.2M2 Mar 31, 2022−13.1%
Raw materials$204.6K2 Mar 31, 2023$107.3K2 Mar 31, 2022+90.7%
Finished goods$829.9K2 Mar 31, 2023$1.1M2 Mar 31, 2022−23.4%

Leadership

Who has led Bionik Laboratories Corp., and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Brian E. Ray2013
  2. Austin Kibler2013
  3. Peter D. Bloch2015
  4. Eric Michel Dusseux2017–2019

Chair

  1. Peter D. Bloch2015
  2. Andre-Jacques Auberton-Herve2021

Chief financial officer

  1. Brian E. Ray2013
  2. Leslie Nadene Markow2015–2019
  3. Daniel Gonsalves2022

Chief operating officer

  1. Michal Prywata2015
201520202025
Board members and other officers (22)

Former names

  • Drywave Technologies, Inc.Aug 14, 2013 to Feb 27, 20153
  • Strategic Dental Management Corp.Feb 8, 2011 to Jun 19, 20133

Timeline

  1. Jun 27, 20238-K Executive or director change40
  2. Jun 16, 20238-K Unregistered sale of shares41
  3. Jun 16, 20238-K Entered a material agreement; New debt or obligation; Unregistered sale of shares42
  4. Jun 15, 20238-K Regulation FD disclosure43
  5. May 23, 20238-K Regulation FD disclosure44
  6. May 4, 20238-K Regulation FD disclosure45
  7. Apr 26, 20238-K Entered a material agreement; New debt or obligation; Unregistered sale of shares46
  8. Feb 23, 20238-K Entered a material agreement; New debt or obligation; Unregistered sale of shares47
  9. Feb 8, 20238-K Results of operations48
  10. Jan 20, 20238-K Shareholder vote49
  11. Dec 20, 20228-K Entered a material agreement; New debt or obligation; Unregistered sale of shares50
  12. Nov 17, 20228-K Entered a material agreement; New debt or obligation; Unregistered sale of shares51
  13. Sep 15, 2017New chief executive Eric Michel Dusseux becomes CEO13
  14. Mar 9, 2015New chief executive Peter D. Bloch becomes CEO14
  15. Mar 27, 2013New chief executive Austin Kibler becomes CEO16
  16. Mar 7, 2013New chief executive Brian E. Ray becomes CEO15

Calendar

When it reported results

  1. Feb 8, 2023Reported quarterly or annual results48
  2. Nov 9, 2022Reported quarterly or annual results52
  3. Aug 10, 2022Reported quarterly or annual results53
  4. Jun 9, 2022Reported quarterly or annual results54
  5. Feb 9, 2022Reported quarterly or annual results55
  6. Nov 10, 2021Reported quarterly or annual results56

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

61 filings to the SEC since October 2021: 2 annual reports, 5 quarterly reports, 32 major events, 14 insider forms, 8 other. The latest 20:

  1. Jun 30, 202315-12G EDGAR
  2. Jun 27, 20238-K EDGAR
  3. Jun 21, 202310-K EDGAR
  4. Jun 21, 2023S-8 POS EDGAR
  5. Jun 21, 20234 OWNERSHIP DOCUMENT EDGAR
  6. Jun 21, 20234 OWNERSHIP DOCUMENT EDGAR
  7. Jun 21, 20234 OWNERSHIP DOCUMENT EDGAR
  8. Jun 21, 20234 OWNERSHIP DOCUMENT EDGAR
  9. Jun 21, 20234 OWNERSHIP DOCUMENT EDGAR
  10. Jun 16, 20238-K EDGAR
  11. Jun 16, 20238-K EDGAR
  12. Jun 15, 20238-K EDGAR
  13. May 31, 2023SD EDGAR
  14. May 23, 20238-K EDGAR
  15. May 4, 20238-K EDGAR
  16. Apr 26, 20238-K EDGAR
  17. Feb 23, 20238-K EDGAR
  18. Feb 8, 202310-Q EDGAR
  19. Feb 8, 20238-K EDGAR
  20. Jan 20, 20238-K EDGAR

The 61 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

3 open-market trades by officers, directors and large owners since October 2021: 3 buys and 0 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Jun 9, 2023Matine CharlesDirectorBuy180,555$0.60$108.3KForm 4
Jun 9, 2023Gaston-Dreyfus RemiDirectorBuy180,555$0.60$108.3KForm 4
Jun 9, 2023AUBERTON-HERVE ANDRE-JACQUESDirectorBuy650,000$0.60$390.0KForm 4

From Forms 4 filed with the SEC.

SEC filer profile

How Bionik Laboratories Corp. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARBionik Laboratories Corp.1
  • CIK0001508381
  • Employer ID (EIN)27-13403461
  • Filer statusNon-accelerated filer<br>smaller reporting company1
  • Incorporated inDelaware1
  • Fiscal year endsMarch 311
  • Industry code (SIC)3842 Orthopedic, Prosthetic & Surgical Appliances & Supplies1
  • Business address80 Coolidge Hill Road, Watertown, MA 024721
  • Phone1-617-926-48001
  • Shares outstanding12,480,431 as of Jun 16, 20232
  • Public float$1.4M as of Sep 30, 20222
  • On EDGAR sinceFeb 8, 20111
  • Filings520 in all: 8-K (197), 4 (61), 10-Q (34), S-1/A (26), 3 (25), 424B3 (19), SC 13D/A (14), UPLOAD (13)1
    All 41 form types

    10-K (12), SC 13D (12), 8-K/A (10), CORRESP (9), DEF 14A (8), EFFECT (8), S-1 (8), SD (6), 10-Q/A (4), 3/A (4), DEF 14C (4), POS AM (4), PRE 14C (4), D (3), DEFA14A (3), NT 10-K (3), NT 10-Q (3), PRE 14A (3), SC TO-I/A (3), 10-KT (2), CT ORDER (2), D/A (2), RW (2), SC 13G (2), SC 14F1 (2), 15-12G (1), 4/A (1), 8-A12G (1), DEFR14A (1), DEL AM (1), S-8 (1), S-8 POS (1), SC TO-I (1)

  • Latest filingsAnnual report (10-K) Jun 21, 2023
    Quarterly report (10-Q) Feb 8, 2023
    Proxy statement (DEF 14A) Dec 7, 2022
    Latest 8-K (8-K) Jun 27, 2023

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49
  50. 50
  51. 51
  52. 52
  53. 53
  54. 54
  55. 55
  56. 56
  57. 57